Current best practice in the evaluation and management of malignant pleural effusions
Malignant pleural effusions (MPEs) are an important cause of cancer-related mortality and morbidity. It is a heterogeneous group of conditions, which leads to debilitating symptoms and confers a poor prognosis. Recent well-designed randomized trials have provided a broader evidence base for an expan...
Main Authors: | Steven Walker, Anna C. Bibby, Nick A. Maskell |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-02-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465816671697 |
Similar Items
-
Contemporary best practice in the management of malignant pleural effusion
by: Coenraad F.N. Koegelenberg, et al.
Published: (2018-06-01) -
Malignant pleural effusion management: keeping the flood gates shut
by: Walker, S, et al.
Published: (2019) -
ERS/EACTS statement on the management of malignant pleural effusions
by: Bibby, A, et al.
Published: (2018) -
ERS/EACTS statement on the management of malignant pleural effusions
by: Bibby, AC, et al.
Published: (2018) -
Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma
by: Alex Dipper, et al.
Published: (2021-06-01)